Table 2.
Clinical presentation at admission and virus identified.
| Syndrome (samples: n) |
||||||
|---|---|---|---|---|---|---|
| Upper respiratory infections (243) | Lower respiratory infections (723) |
Total samples (966) | ||||
| Rhinopharyngitidis and ORL syndrome (243) | Bronchiolitis (360) | Pneumonia (112) | Flu and flu syndrome (166) | Asthma (85) | ||
| RSV | 40 | 173 | 31 | 15 | 22 | 281 |
| RV | 64 | 43 | 18 | 5 | 26 | 156 |
| IV | 11 | 3 | 3 | 91 | 3 | 111 |
| ADV | 15 | 5 | 7 | 10 | 3 | 40 |
| CoV | 12 | 8 | 8 | 6 | 1 | 35 |
| MPV | 8 | 19 | 5 | 3 | 4 | 39 |
| PiV | 12 | 8 | 2 | 2 | 3 | 27 |
| Number of co-infectionsa | 23 | 77 | 22 | 28 | 18 | 168 |
| Total positive | 185 | 336 | 96 | 160 | 80 | 857 |
RV: rhinoviruses, RSV: respiratory syncytial virus, IV: influenza A and B viruses, ADV: adenovirus, MPV: human metapneumovirus, CoV: coronaviruses, PiV: parainfluenzae viruses.
Bold numbers represent the most prevalent pathogen linked to a syndrome.
a
Co-infections involved either one virus or the other.